Invention Grant
US07662811B2 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
有权
1,2,3,4-四氢吡嗪-2-基乙酰胺及其使用方法
- Patent Title: 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
- Patent Title (中): 1,2,3,4-四氢吡嗪-2-基乙酰胺及其使用方法
-
Application No.: US11182216Application Date: 2005-07-15
-
Publication No.: US07662811B2Publication Date: 2010-02-16
- Inventor: Benny C. Askew, Jr. , Toshihiro Aya , Kaustav Biswas , Guolin Cai , Jian J. Chen , Nianhe Han , Qingyian Liu , Thomas Nguyen , Nobuko Nishimura , Rana Nomak , Tanya Peterkin , Wenyuan Qian , Kevin Yang , Chester Chenguang Yuan , Jiawang Zhu , Derin C. D'Amico , Jason B. Human , Qi Huang
- Applicant: Benny C. Askew, Jr. , Toshihiro Aya , Kaustav Biswas , Guolin Cai , Jian J. Chen , Nianhe Han , Qingyian Liu , Thomas Nguyen , Nobuko Nishimura , Rana Nomak , Tanya Peterkin , Wenyuan Qian , Kevin Yang , Chester Chenguang Yuan , Jiawang Zhu , Derin C. D'Amico , Jason B. Human , Qi Huang
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Rekha P. Bansal
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A61K31/00 ; A61K31/55 ; A61K31/4965 ; C07D401/00 ; C07D403/00 ; C07D405/00 ; C07D409/00 ; C07D411/00 ; C07D413/00 ; C07D417/00 ; C07D419/00

Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Public/Granted literature
- US20060025400A1 1,2,3,4-Tetrahydropyrazin-2-yl acetamides and methods of use Public/Granted day:2006-02-02
Information query
IPC分类: